IL-33 promotes colon cancer stemness. IL-33 treatment in vitro increased HT29 and primary human CRC cell expression of stem markers NANOG, NOTCH3, OCT3, OCT4 and Lgr5, and enhanced sphere formation. Here, NOTCH3 is linked to malignant colon neoplasm.